Paul Porter
Medical Oncology · Grosse Pointe Woods, MINPI 1588678155
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,875 of the $7,109 with a category attached, or 68.6%. Incyte Corporation accounts for 69.7% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $5,688 and has fallen 96.8% since, to $183 in 2021.
Across 100 payments — averaging $71.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$5K
- GSK$560
- Athenex Pharmaceutical Division, LLC$325
- Amgen$320
- Johnson & Johnson$197
- Novartis$138
- plus $615 from 15 others
What the payments were for
- Consulting fees$4,87569%
- Speaking & faculty fees$3255%
- Travel & lodging$4807%
- Food & beverage$1,22817%
- Education$2003%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 6 | $4,955 |
| GSK | 6 | $560 |
| Athenex Pharmaceutical Division, LLC | 2 | $325 |
| Amgen | 17 | $320 |
| Johnson & Johnson(2 entities) | 10 | $197 |
| Novartis | 13 | $138 |
| Clovis Oncology, Inc. | 9 | $93 |
| AstraZeneca | 5 | $75 |
| Pfizer | 6 | $71 |
| Gilead(2 entities) | 5 | $70 |
| Merck | 4 | $62 |
| Lilly USA, LLC | 3 | $38 |
| Dova Pharmaceuticals | 2 | $35 |
| Seagen Inc. | 2 | $31 |
| Genentech USA, Inc. | 2 | $30 |
| Sanofi | 2 | $23 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Fortovia Therapeutics, Inc. | 2 | $20 |
| Exelixis Inc. | 1 | $18 |
| Beigene USA, Inc. | 1 | $16 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEJULA$425
- Oral Paclitaxel$150
- Encequidar$150
How this compares
$7,109 in reported general payments places this provider in the 65th percentile of 170 medical oncology providers in Michigan.
Other medical oncology in Grosse Pointe Woods
- Wajahat KhanGrosse Pointe Woods$190K
- Harry ErbaAnn Arbor$1.1M
- Philip PhilipDetroit$494K
- Shirish GadgeelDetroit$413K
- Patricia Lo RussoDetroit$322K
- Ammar SukariDetroit$273K
- Sami BrakeGrand Rapids$251K
- Frank WeinbergAnn Arbor$195K
- Charles SchifferDetroit$165K
- Francis WordenAnn Arbor$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.